COVID-19
According to reports, 15 employees who attended a management meeting in Boston have now tested positive for the virus.
According to a company statement, the three employees are doing well and “improving under the care of their healthcare providers.”
Biopharma companies, government regulatory and health agencies and academic centers are stepping forward and working to test or develop vaccines and therapeutics for the disease.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
As the coronavirus outbreak that causes COVID-19 escalates, biopharma companies and government agents are working quickly to develop and test a vaccine, although most estimates are it will take 12 to 18 months before it could get to market.
The mandatory work-from-home policy will remain in effect through March 31, but could be extended depending on circumstances.
Multiple pharma conferences set to take place in the United States this month will proceed as planned, but event organizers are urging precaution against the coronavirus.
According to a Wall Street Journal report, Takeda has assigned about 40 staffers to work on the project, which was only conceptual a few weeks ago until they triggered the program.
Scangos, who currently helms Vir Biotechnology, is expected to coordinate the industry’s response to the increasing coronavirus threat.
The novel coronavirus that causes the disease COVID-19 continues to spread and has now been diagnosed in more than 50 countries.
PRESS RELEASES